This led to a significant decrease in NT-proBNP concentration (weighted mean difference {WMD}: -71.91 {-138.43, -5.39}; p = 0.03) post MI in the sacubitril/valsartan combination group as compared to the ARB usage alone, as illustrated in Figure 8. This evidence concerns the gene NPPB and myocardial infarction.